Solventum, an American healthcare company spun off from 3M in 2024, has completed the sale of its purification and filtration business to Thermo Fisher Scientific for approximately USD 4 billion in cash, subject to customary adjustments, effective 1 September 2025.
The divested business is a leading global provider of purification and filtration technologies used in the production of biologics, as well as in medical technologies and industrial applications. It operates worldwide, with sites across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region.
Paksoy is pleased to announce that a team led by partner Stéphanie Beghe Sönmez and associates Meriç Saçak Albaş and Cansın Taner acted as Turkish counsel to Solventum, alongside Cleary Gottlieb Steen & Hamilton, which served as global counsel on this multijurisdictional transaction.
Share
Related persons
You can contact us for detailed information.


Legal Information
This is for information purposes; it is not legal advice. As laws and their interpretation may change, please consult Turkish legal counsel to confirm the current position and obtain advice tailored to your circumstances before making any decision or taking action in relation to your matter in Türkiye. All rights reserved.
You May Be Interested In
30 September 2026
Paksoy advises the Kocadağ Family on the sale of its 70% stake in Espressolab
On 23 September 2026, the Kocadağ Family entered into a share purchase agreement to sell their 70% stake in Espressolab, a leading local…
28 September 2026
Serdar Paksoy, has been named Türkiye Litigator of the Year at the Benchmark Litigation Europe Awards 2026
We are pleased to announce that our Founder & Senior Partner, Serdar Paksoy, has been named Türkiye Litigator of the Year at the Benchmark…
17 September 2026
Paksoy advises Digital Realty on its entry into Türkiye through a joint venture with Rönesans Holding
Digital Realty, the world’s largest cloud- and carrier-neutral data center platform, has entered the Turkish market through a 50/50 joint…
7 September 2026
Paksoy advises EBRD on a USD 207 million loan to Enerjisa
Paksoy advises EBRD on a USD 207 million loan to Enerjisa. The loan will be used to finance the modernisation and construction investments…
31 August 2026
Paksoy advises Point72 on its investment in HubX
On 28 August 2026, Point72 Private Investments, one of the world’s leading alternative investment firms, completed an investment of up to…
10 August 2026
Paksoy closes Fysol’s acquisition of shares of Beşler Glass Fiber
Fysol, a France-headquartered player in the glass fiber industry backed by private equity firm Blantyre Capital, has completed the…
